Track topics on Twitter Track topics that are important to you
FT. LAUDERDALE, FL -- (Marketwired) -- 02/21/17 -- MediXall Group Inc. (OTCQB: MDXL) is a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry.
MediXall today has signed a Strategic Agreement with Renaissance Health System of Florida, Inc. (RHSFL) that would provide MediXall with access to more than 2,000 healthcare providers in the State of Florida. Together, these more than 2,000 healthcare providers comprise one of the largest credentialed provider networks within geographic areas that include more than 70% of the nearly 21 million residents in the State.
The agreement calls for MediXall, in collaboration with RHSFL, to contact this provider network and offer them the opportunity to be "early adopters" on the MediXaid e-commerce platform presently in development. RHSFL had identified and credentialed some of the best healthcare practices in wide range of fields throughout the 37 counties in Florida; practices that range from diagnostic centers, primary care, specialty care, as well as ancillary care physician practices.
Carl L. Larsen, MediXall Chief Operating Officer, noted that over a five-year period RHSFL developed and maintained one of the most enviable networks of healthcare providers in the State of Florida. "We will use the access to these providers to bring them onboard in what we believe will be a revolutionary new healthcare marketplace providing consumers the free market competition to achieve the best cost, high transparency and a convenient and uncomplicated internet accessible platform that meets the requirements of today's discriminating consumer. Our marketing campaign is being finalized and will begin shortly in anticipation of the launch of our MediXaid platform by the summer of 2017."
About MediXall Group, Inc.
MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol "MDXL." The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall's first acquisition was MediXaid, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company's ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Steve Bryant Vice President, Investor Relations MediXall Group of FL 954.908.3481 NEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...